ES2183650T3 - Cristal de diuridina tetrafosfato o sal correspondiente y procedimiento de fabricacion. - Google Patents

Cristal de diuridina tetrafosfato o sal correspondiente y procedimiento de fabricacion.

Info

Publication number
ES2183650T3
ES2183650T3 ES99970090T ES99970090T ES2183650T3 ES 2183650 T3 ES2183650 T3 ES 2183650T3 ES 99970090 T ES99970090 T ES 99970090T ES 99970090 T ES99970090 T ES 99970090T ES 2183650 T3 ES2183650 T3 ES 2183650T3
Authority
ES
Spain
Prior art keywords
tetraphosphate
diuridine
crystal
manufacturing procedure
corresponding salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99970090T
Other languages
English (en)
Inventor
Hideaki Maeda
Toshio Yamada
Hiroshi Sato
Yutaka Noda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Corp
Original Assignee
Yamasa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Corp filed Critical Yamasa Corp
Application granted granted Critical
Publication of ES2183650T3 publication Critical patent/ES2183650T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Cristales de P1, P4-di(uridin-5¿-)tetrafosfato o de una sal del mismo.
ES99970090T 1998-10-02 1999-10-01 Cristal de diuridina tetrafosfato o sal correspondiente y procedimiento de fabricacion. Expired - Lifetime ES2183650T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28166398 1998-10-02
JP17068199 1999-06-17

Publications (1)

Publication Number Publication Date
ES2183650T3 true ES2183650T3 (es) 2003-03-16

Family

ID=26493605

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99970090T Expired - Lifetime ES2183650T3 (es) 1998-10-02 1999-10-01 Cristal de diuridina tetrafosfato o sal correspondiente y procedimiento de fabricacion.

Country Status (21)

Country Link
US (2) US6458946B1 (es)
EP (1) EP1043329B1 (es)
JP (2) JP3247685B2 (es)
KR (1) KR100475008B1 (es)
CN (2) CN100396692C (es)
AT (1) ATE222920T1 (es)
AU (1) AU747096C (es)
BR (2) BR9914453A (es)
CA (1) CA2345624C (es)
CZ (1) CZ300402B6 (es)
DE (1) DE69902624T2 (es)
EA (2) EA003167B1 (es)
ES (1) ES2183650T3 (es)
HU (1) HU228681B1 (es)
IL (1) IL142181A (es)
MX (1) MXPA01003377A (es)
NO (1) NO317305B1 (es)
NZ (1) NZ510748A (es)
PL (1) PL199434B1 (es)
SK (1) SK283729B6 (es)
WO (1) WO2000020430A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818629B2 (en) 1997-02-10 2004-11-16 Inspire Pharmaceuticals, Inc. Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate
US7223744B2 (en) 1997-02-10 2007-05-29 Inspire Pharmaceuticals, Inc. Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
US7078391B2 (en) 1997-02-10 2006-07-18 Inspire Pharmaceuticals, Inc. Method of treating edematous retinal disorders
US6872710B2 (en) 1997-07-25 2005-03-29 Inspire Pharmaceuticals, Inc. Di(uridine 5′)-tetraphosphate and salts thereof
WO2001002416A1 (en) * 1999-06-30 2001-01-11 Yamasa Corporation Dinucleotide crystals
US6867199B2 (en) 2000-08-21 2005-03-15 Inspire Pharmaceuticals, Inc. Dinucleoside polyphosphate compositions and their therapeutic use
CN100363376C (zh) * 2006-06-12 2008-01-23 南京工业大学 一种5’-核苷三磷酸钠盐的结晶方法
WO2017002827A1 (ja) * 2015-06-29 2017-01-05 ヤマサ醤油株式会社 Ｐ１，ｐ４－ビス（５'－ウリジル）テトラホスフェート結晶の保管方法
JP6774663B2 (ja) * 2016-10-25 2020-10-28 ヤマサ醤油株式会社 Ｐ１，ｐ４−ジ（ウリジン５’−）テトラホスフェートの精製方法
KR20180091689A (ko) 2017-11-06 2018-08-16 주식회사 종근당 무정형 디뉴클레오사이드 폴리포스페이트 화합물의 제조방법
CN109021049B (zh) * 2018-06-14 2020-12-08 扬子江药业集团北京海燕药业有限公司 一种尿苷5′-二磷酸-苯并咪唑二钠的合成方法
KR20210110055A (ko) * 2020-02-28 2021-09-07 주식회사 종근당바이오 P1, p4-디(우리딘 5'-)테트라포스페이트 나트륨염 4 수화물 결정형 a의 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423694B1 (en) * 1996-02-21 2002-07-23 Inspire Pharmaceuticals, Inc. Method of treating otitis media with uridine triphosphates and related compounds
NZ332426A (en) * 1996-03-27 2000-09-29 Univ North Carolina Method of treating diseases involving dysfunction of ciliary movement such as ciliary dyskinesia and infertility with uridine triphosphates (UTP) and related compounds
US6319908B1 (en) * 1996-07-03 2001-11-20 Inspire Pharmaceuticals, Inc. Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
US5763447C1 (en) * 1996-07-23 2002-05-07 Inspire Pharmaceuticals Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
KR20010013797A (ko) * 1997-07-25 2001-02-26 인스파이어 파마슈티컬스 인코퍼레이티드 디(우리딘 5'-테트라포스페이트) 염 및 그의 제조방법과용도

Also Published As

Publication number Publication date
JP3824894B2 (ja) 2006-09-20
EA200100407A1 (ru) 2001-10-22
HUP0103754A2 (hu) 2002-04-29
PL199434B1 (pl) 2008-09-30
CZ20011028A3 (cs) 2001-08-15
AU747096B2 (en) 2002-05-09
EA004513B1 (ru) 2004-04-29
AU747096C (en) 2003-01-23
CN1502622A (zh) 2004-06-09
KR20020013471A (ko) 2002-02-20
CN1321163A (zh) 2001-11-07
JP2002053590A (ja) 2002-02-19
CA2345624A1 (en) 2000-04-13
NO317305B1 (no) 2004-10-04
IL142181A (en) 2005-12-18
WO2000020430A1 (en) 2000-04-13
KR100475008B1 (ko) 2005-03-08
NZ510748A (en) 2002-10-25
EP1043329A1 (en) 2000-10-11
ATE222920T1 (de) 2002-09-15
DE69902624D1 (de) 2002-10-02
HUP0103754A3 (en) 2003-01-28
IL142181A0 (en) 2002-03-10
BRPI9917911B1 (pt) 2016-08-23
US20020156269A1 (en) 2002-10-24
EA003167B1 (ru) 2003-02-27
JP3247685B2 (ja) 2002-01-21
AU6000899A (en) 2000-04-26
EA200200695A1 (ru) 2002-10-31
NO20011634D0 (no) 2001-03-30
SK283729B6 (sk) 2003-12-02
DE69902624T2 (de) 2003-04-03
CZ300402B6 (cs) 2009-05-13
CN1151166C (zh) 2004-05-26
EP1043329A4 (en) 2001-03-14
EP1043329B1 (en) 2002-08-28
US6458946B1 (en) 2002-10-01
PL347070A1 (en) 2002-03-11
BR9914453A (pt) 2001-05-22
US6780988B2 (en) 2004-08-24
HU228681B1 (en) 2013-05-28
CA2345624C (en) 2006-12-05
NO20011634L (no) 2001-05-30
CN100396692C (zh) 2008-06-25
MXPA01003377A (es) 2003-06-24
SK4402001A3 (en) 2001-11-06

Similar Documents

Publication Publication Date Title
ES2183650T3 (es) Cristal de diuridina tetrafosfato o sal correspondiente y procedimiento de fabricacion.
DK1333887T3 (da) Kombinationsbehandling omfattende antidiabetiske og antikonvulsive midler
NO954427D0 (no) Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS
FI935778A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten
NO893400L (no) Hiv protease inhibitorer egnet for behandling av aids.
EA200500630A1 (ru) Кристаллические формы азитромицина
EP0648014A3 (en) Crystal resonator.
HUP0301320A2 (hu) Glikopeptid-foszfonát-származékok
UY26380A1 (es) Inhibidores de fab i
SE9604793L (sv) Nya Kristallmodifikationer
ES2192101T3 (es) Formas cristalinas de eto2c-ch2-(r)cgl-aze-pab-oh.
IS4639A (is) Nýir þrombínhemlar, framleiðsla þeirra og notkun
AR003476A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol
CL2010000223A1 (es) Mezcla herbicida que contiene tritosulfurona o una sal de la misma y por lo menos otro herbicida seleccionado entre flucarbazona y procarbazona o sales de las mismas; procedimiento para controlar el crecimiento de plantas indeseadas; y su uso (div. sol. 2128-01).
DE60105025D1 (de) Pharmazeutische verbindungen zur behandlung von chronisch-obstruktiver bronchopneumonie
NO20033161L (no) Linsepleieprodukt inneholdende dexpantenol
FI935780A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten
DE69311918D1 (de) Quarzkristalldruckwandler
FI935779L (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten
ES2052718T3 (es) Composicion desinfectante y esterilizante.
AU5628800A (en) Substituted benzamide inhibitors of rhinovirus 3c protease
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
DK1343896T3 (da) Lille syreoplöseligt sporeprotein og anvendelser deraf
DE69206203D1 (de) Längsquarz-Kristallresonator.
DE60220064D1 (de) Pyramidenfilter